ICECP™ cancer cell panel screening allows robust, flexible, and tailored profiling of test agents on 500+ cancer cell lines, encompassing various assays such as 2D proliferation, 3D proliferation, colony formation, and apoptosis, with no assay timeline constraints. For generated drug resistant cell lines, we perform RNA-seq-based bioinformatic analysis to investigate the mechanism. Utilizing our in-house algorithm, we can provide detailed information about differential gene expression, enriched pathway and featured gene profiling.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
